| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +3.39 M | 44.7% | $0.21 | +$696 K |
| Sells | 1 | -4.2 M | 55.3% | $0.19 | -$812 K |
| Net | 0 | -805 K | -10.6% | -$115 K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Yair Schneid | 10%+ Owner | $2.1 M | +$696 K | +49.6% | Apr 17, 2024 |
| Rochel Soffer | 10%+ Owner | $1.15 M | Apr 16, 2024 | ||
| Mel Sorensen | President and CEO, Director | $746 K | Mar 10, 2023 | ||
| Robert A. Beardsley | Chief Operating Officer | $243 K | Feb 25, 2023 | ||
| Altamont Pharmaceutical Holdings, LLC | 10%+ Owner | $158 K | -$812 K | -83.7% | Dec 31, 2023 |
| Mark Bachleda | Chief Commercial Officer | $24.7 K | Mar 16, 2023 | ||
| Lawrence M. Alleva | Director | $23.3 K | Jul 1, 2023 | ||
| Chris Degnan | Chief Financial Officer | $22.5 K | Mar 13, 2023 | ||
| Michael Powell | Director | Jun 14, 2023 | |||
| Eugene P. Kennedy | Chief Medical Officer | Feb 25, 2023 | |||
| Kevin G. Lokay | Director | Jun 14, 2023 | |||
| Emmett Cunningham | Director | Jun 14, 2023 | |||
| Linda West | Director | Jul 1, 2023 | |||
| Jennifer Evans Stacey | Chief Legal & Compliance Officer | Feb 25, 2023 | |||
| Holmlund Jon T | Chief Medical Officer | Feb 28, 2022 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|